A carregar...

B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis

Recent preclinical and clinical studies lend support to the notion that B-cell depletion is a promising therapeutic target in patients with diffuse cutaneous systemic sclerosis. A recent open-label trial provides further evidence showing marked effects of rituximab treatment on skin thickening, func...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: van Laar, Jacob M
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2888215/
https://ncbi.nlm.nih.gov/pubmed/20441607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar2977
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!